| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CIO | Pres&Chief Investment Officer | See Remarks
1 company
Sukhatme Mayukh is a President &CIO at Roivant Sciences Ltd.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $591.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | ROIV Roivant Sciences Ltd. | President &CIO | Sale+OE | 1,330,868 | $21.72 | $28,902,500.47 | -3.3% | +27.6% | - | |
| Dec 17, 2025 | ROIV Roivant Sciences Ltd. | President &CIO | Sale+OE | 26,831 | $23.09 | $619,527.79 | -0.1% | +24.7% | - | |
| Dec 26, 2024 | ROIV Roivant Sciences Ltd. | Pres&Chief Investment Officer | Sale+OE | 886,237 | $12.01 | $10,641,738.95 | -1.5% | -13.0% | +85.3% | |
| Dec 18, 2024 | ROIV Roivant Sciences Ltd. | Pres&Chief Investment Officer | Sale+OE | 412,584 | $12.05 | $4,971,637.20 | -2.1% | -8.4% | +86.4% |